What you should know:
1. No reports of device subsidence were found in the study, which supports the implant’s ability to conform to patients’ endplate geometry.
2. The articles present clinical outcomes and discuss design features that may contribute to FlareHawk’s efficacy.
3. The implant is the flagship product of spine device manufacturer Integrity Implants.
4. FlareHawk is intended for spinal intervertebral body fusion with autogenous bone graft and/or allogeneic bone graft composed of cancellous and/or corticocancellous bone in skeletally mature patients with degenerative disc disease following discectomy.
Click here for more details on the studies.
More articles on devices:
The most controversial trends in spine from 10 surgeons
Dr. Ali Baaj to build UArizona-Banner spine program from scratch in new role
Investment firm bets big on spine device company that rejected Stryker takeover
